Cell cycle on the crossroad of tumorigenesis and cancer therapy

J Liu, Y Peng, W Wei - Trends in cell biology, 2022 - cell.com
Aberrancy in cell cycle progression is one of the fundamental mechanisms underlying
tumorigenesis, making regulators of the cell cycle machinery rational anticancer therapeutic …

[HTML][HTML] Structural insights into protein regulation by phosphorylation and substrate recognition of protein kinases/phosphatases

SH Seok - Life, 2021 - mdpi.com
Protein phosphorylation is one of the most widely observed and important post-translational
modification (PTM) processes. Protein phosphorylation is regulated by protein kinases, each …

[HTML][HTML] Discovery of pyrazolo [3, 4-d] pyrimidine and pyrazolo [4, 3-e][1, 2, 4] triazolo [1, 5-c] pyrimidine derivatives as novel CDK2 inhibitors: synthesis, biological and …

IF Nassar, MTA Aal, WA El-Sayed, MAE Shahin… - RSC …, 2022 - pubs.rsc.org
CDK2 inhibition is an appealing target for cancer treatment that targets tumor cells in a
selective manner. A new set of small molecules featuring the privileged pyrazolo [3, 4-d] …

From structure modification to drug launch: A systematic review of the ongoing development of cyclin-dependent kinase inhibitors for multiple cancer therapy

Z Shi, L Tian, T Qiang, J Li, Y Xing, X Ren… - Journal of medicinal …, 2022 - ACS Publications
Herein, we discuss more than 50 cyclin-dependent kinase (CDK) inhibitors that have been
approved or have undergone clinical trials and their therapeutic application in multiple …

[HTML][HTML] Integrative bioinformatics approaches to map potential novel genes and pathways involved in ovarian cancer

SU Kumar, DT Kumar, R Siva, CGP Doss… - … in bioengineering and …, 2019 - frontiersin.org
Background and aims: Ovarian cancer (OC) is the seventh most commonly detected cancer
among women. This study aimed to map the hub and core genes and potential pathways …

Prediction of protein-protein interactions based on ensemble residual convolutional neural network

H Gao, C Chen, S Li, C Wang, W Zhou, B Yu - Computers in Biology and …, 2023 - Elsevier
With the development of bio-medical big data, the prediction of protein-protein interactions
(PPIs) with the help of deep learning (DL) has attracted much attention for the study of …

[HTML][HTML] Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding

EB Faber, L Sun, J Tang, E Roberts… - Nature …, 2023 - nature.com
Compared to most ATP-site kinase inhibitors, small molecules that target an allosteric pocket
have the potential for improved selectivity due to the often observed lower structural …

Novel N-bridged pyrazole-1-carbothioamides With Potential Antiproliferative Activity: design, synthesis, In Vitro and In Silico Studies

IH El Azab, EM Saied, AA Osman… - Future Medicinal …, 2021 - Taylor & Francis
Thiazole-substituted pyrazole is an important structural feature of many bioactive
compounds, including antiviral, antitubercular, analgesic and anticancer agents. Herein we …

Development of CDK2 and CDK5 dual degrader TMX‐2172

M Teng, J Jiang, Z He, NP Kwiatkowski… - Angewandte …, 2020 - Wiley Online Library
Abstract Cyclin‐dependent kinase 2 (CDK2) is a potential therapeutic target for the treatment
of cancer. Development of CDK2 inhibitors has been extremely challenging as its ATP …

Pharmacological relevance of CDK inhibitors in Alzheimer's disease

N Malhotra, R Gupta, P Kumar - Neurochemistry International, 2021 - Elsevier
Evidence suggests that cell cycle activation plays a role in the pathophysiology of
neurodegenerative diseases. Alzheimer's disease is a progressive, terminal …